Calcium-channel blockers and end-stage renal disease: pharmacokinetic and pharmacodynamic considerations
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Nephrology,Internal Medicine
Reference132 articles.
1. Current status of calcium channel blockers in patients with cardiovascular disease
2. Calcium-Antagonist Drugs
3. Clinical epidemiology of cardiovascular disease in chronic renal disease
4. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease
5. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Dose, dosage regimen, and dose adjustment in organ failure;Biopharmaceutics and Pharmacokinetics Considerations;2021
2. Pharmacologic Therapies for Aortic Stiffness in End-Stage Renal Disease: A Systematic Review and Meta-Analysis;Canadian Journal of Kidney Health and Disease;2020-01
3. Pharmacokinetic and pharmacodynamic considerations in the treatment of the elderly patient with hypertension;Expert Opinion on Drug Metabolism & Toxicology;2019-03-16
4. Managing hypertension in patients with chronic kidney disease;Journal of the American Academy of Physician Assistants;2014-09
5. Antihypertensive agents for dialysis patients;Cochrane Database of Systematic Reviews;2014-01-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3